Literature DB >> 36018449

The impact of noradrenergic neurotoxin DSP-4 and noradrenaline transporter knockout (NET-KO) on the activity of liver cytochrome P450 3A (CYP3A) in male and female mice.

Ewa Bromek1, Przemysław Jan Danek1, Jacek Wójcikowski1, Agnieszka Basińska-Ziobroń1, Renata Pukło1, Joanna Solich2, Marta Dziedzicka-Wasylewska2, Władysława Anna Daniel3.   

Abstract

BACKGROUND: Our earlier studies have shown that the brain noradrenergic system regulates cytochrome P450 (CYP) in rat liver via neuroendocrine mechanism. In the present work, a comparative study on the effect of intraperitoneal administration of the noradrenergic neurotoxin DSP-4 and the knockout of noradrenaline transporter (NET-KO) on the CYP3A in the liver of male and female mice was performed.
METHODS: The experiments were conducted on C57BL/6J WT and NET-/- male/female mice. DSP-4 was injected intraperitoneally as a single dose (50 mg/kg ip.) to WT mice. The activity of CYP3A was measured as the rate of 6β-hydroxylation of testosterone in liver microsomes. The CYP3A protein level was estimated by Western blotting.
RESULTS: DSP-4 evoked a selective decrease in the noradrenaline level in the brain of male and female mice. At the same time, DSP-4 reduced the CYP3A activity in males, but not in females. The level of CYP3A protein was not changed. The NET knockout did not affect the CYP3A activity/protein in both sexes.
CONCLUSIONS: The results with DSP-4 treated mice showed sex-dependent differences in the regulation of liver CYP3A by the brain noradrenergic system (with only males being responsive), and revealed that the NET knockout did not affect CYP3A in both sexes. Further studies into the hypothalamic-pituitary-gonadal hormones in DSP-4 treated mice may explain sex-specific differences in CYP3A regulation, whereas investigation of monoaminergic receptor sensitivity in the hypothalamic/pituitary areas of NET-/- mice will allow for understanding a lack of changes in the CYP3A activity in the NET-KO animals.
© 2022. The Author(s).

Entities:  

Keywords:  Brain; Cytochrome P450; DSP-4 neurotoxin; Liver; NET knockout; Neuroendocrine regulation; Noradrenergic system

Mesh:

Substances:

Year:  2022        PMID: 36018449      PMCID: PMC9584982          DOI: 10.1007/s43440-022-00406-8

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.919


  47 in total

1.  The regulation of liver cytochrome P450 expression and activity by the brain serotonergic system in different experimental models.

Authors:  Ewa Bromek; Władysława Anna Daniel
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-01-18       Impact factor: 4.481

2.  The role of the dorsal noradrenergic pathway of the brain (locus coeruleus) in the regulation of liver cytochrome P450 activity.

Authors:  Marta Kot; Anna Sadakierska-Chudy; Anna Haduch; Marta Rysz; Ewa Bromek; Krystyna Gołembiowska; Wladyslawa A Daniel
Journal:  Eur J Pharmacol       Date:  2015-01-28       Impact factor: 4.432

3.  Norepinephrine transporter knock-out alters expression of the genes connected with antidepressant drugs action.

Authors:  Joanna Solich; Magdalena Kolasa; Maciej Kusmider; Agata Faron-Gorecka; Paulina Pabian; Dariusz Zurawek; Kinga Szafran-Pilch; Marta Dziedzicka-Wasylewska
Journal:  Brain Res       Date:  2014-11-04       Impact factor: 3.252

Review 4.  Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man.

Authors:  G G Gibson; N J Plant; K E Swales; A Ayrton; W El-Sankary
Journal:  Xenobiotica       Date:  2002-03       Impact factor: 1.908

5.  Hypothalamic alpha 2A-adrenoceptors stimulate growth hormone release in the rat.

Authors:  G B Makara; D T Kiem; E S Vizi
Journal:  Eur J Pharmacol       Date:  1995-12-04       Impact factor: 4.432

6.  Cytochrome P450 2D (CYP2D) enzyme dysfunction associated with aging and serotonin deficiency in the brain and liver of female Dark Agouti rats.

Authors:  Anna Haduch; Przemysław J Danek; Wojciech Kuban; Renata Pukło; Natalia Alenina; Joanna Gołębiowska; Piotr Popik; Michael Bader; Władysława A Daniel
Journal:  Neurochem Int       Date:  2021-11-13       Impact factor: 3.921

Review 7.  Sex differences in the expression of hepatic drug metabolizing enzymes.

Authors:  David J Waxman; Minita G Holloway
Journal:  Mol Pharmacol       Date:  2009-05-29       Impact factor: 4.436

8.  Disruption of glucocorticoid receptors in the noradrenergic system leads to BDNF up-regulation and altered serotonergic transmission associated with a depressive-like phenotype in female GR(DBHCre) mice.

Authors:  Piotr Chmielarz; Grzegorz Kreiner; Marta Kot; Agnieszka Zelek-Molik; Marta Kowalska; Monika Bagińska; Władysława Anna Daniel; Irena Nalepa
Journal:  Pharmacol Biochem Behav       Date:  2015-08-07       Impact factor: 3.533

Review 9.  The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences.

Authors:  Jean-Marc Pascussi; Sabine Gerbal-Chaloin; Cédric Duret; Martine Daujat-Chavanieu; Marie-José Vilarem; Patrick Maurel
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

10.  Serum Level of miR-1 and miR-155 as Potential Biomarkers of Stress-Resilience of NET-KO and SWR/J Mice.

Authors:  Joanna Solich; Maciej Kuśmider; Agata Faron-Górecka; Paulina Pabian; Magdalena Kolasa; Beata Zemła; Marta Dziedzicka-Wasylewska
Journal:  Cells       Date:  2020-04-09       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.